Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC34A1 mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of SLC34A1 mRNA | affects expression | 17805973
|
C004656 |
chloroacetaldehyde |
chloroacetaldehyde inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
C004656 |
chloroacetaldehyde |
chloroacetaldehyde results in decreased expression of and results in decreased activity of SLC34A1 protein | decreases activity|decreases expression | 17003823
|
C004656 |
chloroacetaldehyde |
chloroacetaldehyde results in decreased expression of SLC34A1 mRNA | decreases expression | 17003823
|
C004656 |
chloroacetaldehyde |
Mesna inhibits the reaction [chloroacetaldehyde results in decreased activity of SLC34A1 protein] | decreases activity|decreases reaction | 17003823
|
D003520 |
Cyclophosphamide |
Cyclophosphamide analog inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
D003520 |
Cyclophosphamide |
Cyclophosphamide analog results in decreased expression of SLC34A1 protein | decreases expression | 17003823
|
C012353 |
hydroperoxyisophosphamide |
hydroperoxyisophosphamide inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
C012353 |
hydroperoxyisophosphamide |
hydroperoxyisophosphamide results in decreased expression of and results in decreased activity of SLC34A1 protein | decreases activity|decreases expression | 17003823
|
C012353 |
hydroperoxyisophosphamide |
hydroperoxyisophosphamide results in decreased expression of SLC34A1 mRNA | decreases expression | 17003823
|
D007069 |
Ifosfamide |
Ifosfamide analog inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
D007069 |
Ifosfamide |
Ifosfamide analog results in decreased expression of SLC34A1 mRNA | decreases expression | 17003823
|
D007069 |
Ifosfamide |
Ifosfamide analog results in decreased expression of SLC34A1 protein | decreases expression | 17003823
|
D015080 |
Mesna |
Mesna inhibits the reaction [chloroacetaldehyde results in decreased activity of SLC34A1 protein] | decreases activity|decreases reaction | 17003823
|
C025589 |
ochratoxin A |
ochratoxin A results in decreased expression of SLC34A1 mRNA | decreases expression | 16251485
|
D010658 |
Phenylglyoxal |
Phenylglyoxal results in decreased activity of SLC34A1 protein | decreases activity | 12029367
|
D010710 |
Phosphates |
SLC34A1 protein affects the abundance of Phosphates | affects abundance | 16011465
|
D010710 |
Phosphates |
chloroacetaldehyde inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
D010710 |
Phosphates |
Cyclophosphamide analog inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
D010710 |
Phosphates |
hydroperoxyisophosphamide inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
D010710 |
Phosphates |
Ifosfamide analog inhibits the reaction [SLC34A1 protein results in increased transport of Phosphates] | decreases reaction|increases transport | 17003823
|
D010710 |
Phosphates |
SLC34A1 protein results in increased uptake of [Uranium binds to Phosphates] | affects binding|increases uptake | 16476458
|
D016226 |
Phosphorus, Dietary |
SLC34A1 protein affects the reaction [Phosphorus, Dietary results in increased expression of FGF23 protein] | affects reaction|increases expression | 16123154
|
D016226 |
Phosphorus, Dietary |
Phosphorus, Dietary affects the expression of SLC34A1 mRNA | affects expression | 12851780 15166007
|
D016226 |
Phosphorus, Dietary |
Phosphorus, Dietary results in decreased expression of SLC34A1 mRNA | decreases expression | 15618618
|
D011188 |
Potassium |
Potassium affects the expression of SLC34A1 protein | affects expression | 11473652
|
C080938 |
tris(2-carboxyethyl)phosphine |
tris(2-carboxyethyl)phosphine results in decreased activity of SLC34A1 protein | decreases activity | 10926679
|
D014501 |
Uranium |
SLC34A1 protein results in increased uptake of [Uranium binds to Phosphates] | affects binding|increases uptake | 16476458
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.67 | 15014928 |
MESH:D001848 |
Bone Diseases, Developmental |
marker/mechanism |
|
| 9560283 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
2.96 | 16978400 18234424 15136595 12006526 17020986 17388661 15093573 11325840 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
ochratoxin A |
2.96 | 11921183 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.85 | 16124888 16192424 18705752 15721981 16011737 16050911 16097048 16227642 15700767 3786805 10355542 15673190 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.32 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.32 | 19701751 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
4.97 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.56 | 16201981 |
MESH:D019465 |
Craniofacial Abnormalities |
|
ochratoxin A |
3.21 | 20036863 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.08 | 15643279 16989017 18372110 16614059 10700343 10498854 18295254 16651033 18093676 18710439 12913760 15276878 12161096 11948286 16413132 12388444 18433785 17010015 17979934 18483878 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.11 | 11751995 10990075 15331540 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.23 | 18772604 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
2.05 | 16177239 9327722 2869522 19336974 10092053 7120509 16227642 11566570 6884620 15998439 7440962 3786805 21278145 15027814 19085960 17522070 15968718 3732212 10915739 7179309 4309450 6623471 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.29 | 11006010 |
MESH:D005198 |
Fanconi Syndrome |
marker/mechanism |
|
| |
MESH:D005198 |
Fanconi Syndrome |
|
Ifosfamide |
6.64 | 17481685 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
3.22 | 19224547 16239168 15959796 17595544 12631006 61145 16045604 12795759 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.53 | 18705752 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.60 | 11389073 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.11 | 15172196 11014644 16376943 |
MESH:D006394 |
Hemangiosarcoma |
|
chloroacetaldehyde |
5.97 | 10626228 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.36 | 11918545 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.63 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.66 | 19900420 19110552 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
8.48 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
Ifosfamide |
8.48 | 16135485 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.61 | 16899240 |
MESH:D006934 |
Hypercalcemia |
marker/mechanism |
|
| 9560283 |
MESH:D053565 |
Hypercalciuria |
marker/mechanism |
|
| 9560283 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.16 | 15338365 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Potassium |
5.94 | 19822448 |
MESH:D017674 |
Hypophosphatemia |
marker/mechanism |
|
| 9560283 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.43 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.65 | 7193160 16517039 |
MESH:D007674 |
Kidney Diseases |
|
chloroacetaldehyde |
11.07 | 16221203 |
MESH:D007674 |
Kidney Diseases |
|
Ifosfamide |
11.07 | 16221203 17035713 |
MESH:D007674 |
Kidney Diseases |
|
ochratoxin A |
11.07 | 11409539 |
MESH:D007680 |
Kidney Neoplasms |
|
ochratoxin A |
4.54 | 16251485 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.51 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.52 | 17008537 18587576 17658394 17296974 18172266 17802794 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.13 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.05 | 10052129 11830472 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.83 | 16239168 16943688 11903743 17157831 17174718 11408273 21278145 16221502 17334410 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
1.74 | 15362042 12632512 16011737 18277467 16015684 18412020 17976157 18187930 17823541 18156304 16033810 18210741 18279442 14748882 14512876 17869086 18006644 17761835 18205269 12898905 18705752 12958196 13678700 12546737 12445418 18251166 12586293 16136751 17900296 18376398 18317297 17708605 16097048 15338365 16638106 17525996 15925388 12445421 12666154 15673190 15123356 16248980 11481614 15730626 15370692 17557913 17721639 17640975 18481824 18395914 10355542 16192424 17944888 17805973 18166357 17481882 20821823 15876570 16027843 12632514 18429990 18472094 12389079 17631135 14724832 17766677 15959796 17714472 14716833 12649538 17698563 15818738 18263696 12667390 15052691 18418968 15893842 18472332 17922224 18054572 15057751 15650968 15931870 15996030 12609069 18395095 16116963 12741479 18420326 14620537 18339082 14716496 17565644 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.09 | 16246199 15720792 17285989 15830285 16964402 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.24 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.74 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
2.24 | 19294768 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
6.94 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
chloroacetaldehyde |
6.94 | 10626228 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
3.87 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.65 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.21 | 11911406 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
ochratoxin A |
4.11 | 11921183 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
4.87 | 16388313 |
MESH:D001523 |
Mental Disorders |
|
Phosphates |
5.09 | 12686366 |
MESH:D008850 |
Microphthalmos |
|
ochratoxin A |
5.86 | 20036863 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
3.15 | 18854779 |
OMIM:612286 |
NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1 |
marker/mechanism |
|
| |
MESH:D009436 |
Neural Tube Defects |
|
ochratoxin A |
4.48 | 20036863 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.66 | 16115947 8761367 15176712 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.97 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.38 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.79 | 16517039 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.67 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.20 | 11332152 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.83 | 21297632 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
3.93 | 17136230 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.30 | 16636934 |
MESH:D012509 |
Sarcoma |
|
Ifosfamide |
5.70 | 18313854 17710206 15625365 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.88 | 16636934 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Ifosfamide |
6.30 | 15625365 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.60 | 16517039 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.14 | 12837982 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
3.16 | 14692829 |